The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts-Reference-Cited by-同舟云学术

The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts

Published:2023-06-16 Issue:7 Volume:64 Page:28
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Guo Yan¹,Cheng Yanglei¹,Li Hai¹,Guan Hongyu¹,Xiao Haipeng¹,Li Yanbing¹

Affiliation:

1. Department of Endocrinology and Diabetes Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Reference36 articles.

1. Graves’ disease;Smith;N Engl J Med,2016

2. Quality of life in patients with Graves ophthalmopathy;Yeatts;Trans Am Ophthalmol Soc,2005

3. Epidemiology, natural history, risk factors, and prevention of Graves';Bartalena;Orbitopathy Front Endocrinol (Lausanne).,2020

4. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy;Wiersinga;Lancet Diabetes Endocrinol,2017

5. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts;Valyasevi;J Clin Endocrinol Metab,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities;Journal of Pharmaceutical Analysis;2024-08

2. Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets;Journal of Clinical Medicine;2023-12-22